Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
NU E Power Corp. Announces Closing of Non-Brokered Private Placement for $1.7 Million. (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Elanco Animal Health Incorporated ELAN

Healthcare Drug Manufacturers - Specialty & Generic
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. It offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide... see more

Recent & Breaking News (NYSE:ELAN)

Elanco Announces Investment in U.S. Manufacturing and R&D, Driven by Tax, Tariff and Regulatory Clarity

ACCESS Newswire December 17, 2025

Elanco Investor Day Defines New Era as Sustainable Growth Company

PR Newswire December 9, 2025

Elanco's Credelio(TM) CAT (lotilaner) Receives First FDA Emergency Use Authorization (EUA) for Treatment of New World Screwworm (NWS) in Cats

PR Newswire November 21, 2025

Elanco to Participate in the Upcoming Investor Conferences

PR Newswire November 20, 2025

Alloy Partners Launches OneHealth Studio to Create Startups at the Convergence of Animal, Plant and Human Health

PR Newswire November 13, 2025

Our Employees Have Spoken: Elanco Is Great Places To Work Certified

ACCESS Newswire November 11, 2025

Elanco Animal Health Reports Third Quarter 2025 Results

PR Newswire November 5, 2025

Elanco's Credelio(TM) (Lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) Against New World Screwworm (NWS) in Dogs

ACCESS Newswire October 30, 2025

Elanco Announces Expansion of Credelio Quattro(TM) (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio(TM) (lotilaner) Labels, Offering Protection Against Lyme Disease and an Emerging Tick Species

PR Newswire October 27, 2025

Elanco's Credelio(TM) (lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) against New World Screwworm (NWS) in Dogs

PR Newswire October 24, 2025

Elanco to Host Investor Day on December 9

PR Newswire October 16, 2025

Elanco Confirms Date and Conference Call for Third Quarter 2025 Financial Results Announcement

PR Newswire October 1, 2025

Elanco Announces FDA Approves Improved Zenrelia(TM) (ilunocitinib tablets) Label, Removing Vaccine-Induced Disease Language

PR Newswire September 23, 2025

Elanco Innovation Builds Momentum, Credelio Quattro(TM) (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Reaches Blockbuster Status

PR Newswire September 8, 2025

Investigation Alert: Elanco Animal Health Incorporated, Driven Brands Holdings, Hasbro, and TransMedics: Johnson Fistel, PLLP Investigates Claims on Behalf of Investors

GlobeNewswire August 27, 2025

Splenda® Joins Elanco and HATCH to Support 'Nutrition Secure Indianapolis' to Strengthen Family Health Through Nutrition and Education

PR Newswire August 27, 2025

Elanco Animal Health Set to Join S&P MidCap 400; Sarepta Therapeutics to Join S&P SmallCap 600

PR Newswire August 26, 2025

Elanco to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

PR Newswire August 26, 2025

Elanco Coalition Aims to Create Scalable Model For Community Nutrition

ACCESS Newswire August 18, 2025

Elanco CEO Jeff Simmons: Innovation and Sustainability Drive Long-Term Growth

ACCESS Newswire August 15, 2025

Podcasts